Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Badve

Showing results (161-170 of 187) with videos related to

Pageof 19
Sort By:
NPJ Precision Oncology|May 12, 2025
Augmented reality microscopy to bridge trust between AI and pathologistsSunil Badve, George L Kumar, Tobias Lang, et al.
Journal of the National Cancer Institute|June 21, 2014
DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancerStephan Woditschka, Lynda Evans, Renata Duchnowska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2011
Prediction of postoperative recurrence-free survival in non-small cell lung cancer by using an internationally validated gene expression modelRanjana Mitra, Jinseon Lee, Jisuk Jo, et al.
The American Journal of Surgical Pathology|June 14, 2013
Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistryDavid J Dabbs, Stuart J Schnitt, Felipe C Geyer, et al.
JAMA Oncology|January 18, 2019
Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ TreatmentConstance D Lehman, Constantine Gatsonis, Justin Romanoff, et al.
Journal of the National Cancer Institute|March 20, 2019
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast CancerRim S Kim, Nan Song, Patrick G Gavin, et al.
Journal of the National Cancer Institute|December 28, 2020
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working GroupTorsten O Nielsen, Samuel C Y Leung, David L Rimm, et al.
Seminars in Cancer Biology|October 13, 2017
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerMaria Vittoria Dieci, Nina Radosevic-Robin, Susan Fineberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2019
Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c TrialPriyanka Sharma, William E Barlow, Andrew K Godwin, et al.
Histopathology|December 3, 2017
Invasion in breast lesions: the role of the epithelial-stroma barrierEmad A Rakha, Islam M Miligy, Kylie L Gorringe, et al.
Pageof 19

Showing results (161-170 of 187) with videos related to

Sort By:
Pageof 19
NPJ Precision Oncology|May 12, 2025
Augmented reality microscopy to bridge trust between AI and pathologistsSunil Badve, George L Kumar, Tobias Lang, et al.
Journal of the National Cancer Institute|June 21, 2014
DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancerStephan Woditschka, Lynda Evans, Renata Duchnowska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2011
Prediction of postoperative recurrence-free survival in non-small cell lung cancer by using an internationally validated gene expression modelRanjana Mitra, Jinseon Lee, Jisuk Jo, et al.
The American Journal of Surgical Pathology|June 14, 2013
Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistryDavid J Dabbs, Stuart J Schnitt, Felipe C Geyer, et al.
JAMA Oncology|January 18, 2019
Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ TreatmentConstance D Lehman, Constantine Gatsonis, Justin Romanoff, et al.
Journal of the National Cancer Institute|March 20, 2019
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast CancerRim S Kim, Nan Song, Patrick G Gavin, et al.
Journal of the National Cancer Institute|December 28, 2020
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working GroupTorsten O Nielsen, Samuel C Y Leung, David L Rimm, et al.
Seminars in Cancer Biology|October 13, 2017
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerMaria Vittoria Dieci, Nina Radosevic-Robin, Susan Fineberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2019
Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c TrialPriyanka Sharma, William E Barlow, Andrew K Godwin, et al.
Histopathology|December 3, 2017
Invasion in breast lesions: the role of the epithelial-stroma barrierEmad A Rakha, Islam M Miligy, Kylie L Gorringe, et al.
Pageof 19